Blueshift Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,877
Closed -$294K 552
2025
Q4
$294K Buy
+2,877
New +$257K 0.08% 327
2022
Q3
Sell
-6,180
Closed -$249K 693
2022
Q2
$249K Sell
6,180
-3,221
-34% -$160K 0.04% 506
2022
Q1
$623K Buy
+9,401
New +$643K 0.06% 371
2021
Q4
Sell
-2,832
Closed -$354K 997
2021
Q3
$354K Sell
2,832
-20,828
-88% -$2.47M 0.02% 752
2021
Q2
$2.94M Buy
23,660
+21,474
+982% +$2.89M 0.16% 159
2021
Q1
$334K Buy
+2,186
New +$330K 0.03% 605

Other funds holding GH

Blueshift Asset Management's GH Position: Q1 2026 in Review

Blueshift Asset Management sold out of Guardant Health (GH) in Q1 2026, closing a stake of 2,877 shares — an estimated $294K sold.

Blueshift Asset Management first reported a position in GH in Q1 2021 and held it in 6 quarters. The position peaked at $2.94M in Q2 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Blueshift Asset Management reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Blueshift Asset Management sold 2,877 Guardant Health shares in Q1 2026, an estimated $294K.
  • Blueshift Asset Management first reported a position in Guardant Health in Q1 2021 and held it in 6 quarters.
  • Blueshift Asset Management's Guardant Health position peaked at $2.94M in Q2 2021.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Blueshift Asset Management's 13F filing for Q1 2026, filed 14 May 2026.